CTKBCytek Biosciences, Inc.

$553M

FY 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$93M+60.4% YoY

Gross Profit

$52M55.7% margin

Operating Income

$14M14.7% margin

Net Income

$19M20.9% margin

EPS (Diluted)

$0.02

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$14M

Stock-Based Comp.

$611,000

Balance Sheet

Total Assets

$220M

Total Liabilities

$236M

Stockholders' Equity

-$16M

Cash & Equivalents

$165M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$93M	$58M	+60.4%
Gross Profit	$52M	$29M	+80.3%
Operating Income	$14M	-$17M	+179.2%
Net Income	$19M	-$17M	+215.4%

CTKB FY 2020 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena